PF-Atlas › Clinical Trials › NCT00420836
Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study
Tobramycin · Phase 1
Registry ID
NCT00420836
Phase
Phase 1
Status
Completed
Drug / intervention
Tobramycin
Sponsor
Novartis
Start
2006-04
About this trial
Tobramycin is evaluated in NCT00420836, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Novartis. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00420836 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.